Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

March 1, 2024; Volume 65,Issue 3

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine March 1, 2024, 65 (3) 6A;

Discussions with Leaders

  • You have access
    Molecular Imaging in Breast Cancer
    Géraldine Gebhart, Martine Piccart and David Mankoff
    Journal of Nuclear Medicine March 1, 2024, 65 (3) 337-339; DOI: https://doi.org/10.2967/jnumed.124.267461

State of the Art

  • You have access
    Sequencing of Somatostatin-Receptor–Based Therapies in Neuroendocrine Tumor Patients
    Jonathan R. Strosberg, Taymeyah Al-Toubah, Ghassan El-Haddad, Diane Reidy Lagunes and Lisa Bodei
    Journal of Nuclear Medicine March 1, 2024, 65 (3) 340-348; DOI: https://doi.org/10.2967/jnumed.123.265706

Continuing Education

  • You have access
    The Current and Future Roles of Precision Oncology in Advanced Breast Cancer
    Heather Jacene, Eric Dietsche and Jennifer Specht
    Journal of Nuclear Medicine March 1, 2024, 65 (3) 349-356; DOI: https://doi.org/10.2967/jnumed.122.264882

Focus on Molecular Imaging

  • Open Access
    Molecular Imaging of Acute Graft-Versus-Host Disease
    Chiara Bernardi, Valentina Garibotto, Behnaz Mobashwera, Robert S. Negrin, Israt S. Alam and Federico Simonetta
    Journal of Nuclear Medicine March 1, 2024, 65 (3) 357-361; DOI: https://doi.org/10.2967/jnumed.123.266552

Editorial

  • You have access
    Rethinking Dosimetry: The Perils of Extrapolated External-Beam Radiotherapy Constraints to Radionuclide Therapy
    Jonathan Strosberg, Michael S. Hofman, Taymeyah Al-Toubah and Thomas A. Hope
    Journal of Nuclear Medicine March 1, 2024, 65 (3) 362-364; DOI: https://doi.org/10.2967/jnumed.123.267167

Oncology

  • Clinical

    • Imaging of Tumor Stroma Using <sup>68</sup>Ga-FAPI PET/CT to Improve Diagnostic Accuracy of Primary Tumors in Head and Neck Cancer of Unknown Primary: A Comparative Imaging Trial
      Open Access
      Imaging of Tumor Stroma Using 68Ga-FAPI PET/CT to Improve Diagnostic Accuracy of Primary Tumors in Head and Neck Cancer of Unknown Primary: A Comparative Imaging Trial
      Bingxin Gu, Ziyi Yang, Xinyue Du, Xiaoping Xu, Xiaomin Ou, Zuguang Xia, Qing Guan, Silong Hu, Zhongyi Yang and Shaoli Song
      Journal of Nuclear Medicine March 1, 2024, 65 (3) 365-371; DOI: https://doi.org/10.2967/jnumed.123.266556
    • Diagnostic Accuracy of <sup>68</sup>Ga-FAPI Versus <sup>18</sup>F-FDG PET in Patients with Various Malignancies
      You have access
      Diagnostic Accuracy of 68Ga-FAPI Versus 18F-FDG PET in Patients with Various Malignancies
      Nader Hirmas, Rainer Hamacher, Miriam Sraieb, Lukas Kessler, Kim M. Pabst, Francesco Barbato, Helena Lanzafame, Stefan Kasper, Michael Nader, Claudia Kesch, Bastian von Tresckow, Hubertus Hautzel, Clemens Aigner, Martin Glas, Martin Stuschke, Sherko Kümmel, Philipp Harter, Celine Lugnier, Waldemar Uhl, Boris Hadaschik, Viktor Grünwald, Jens T. Siveke, Ken Herrmann and Wolfgang P. Fendler
      Journal of Nuclear Medicine March 1, 2024, 65 (3) 372-378; DOI: https://doi.org/10.2967/jnumed.123.266652
    • Diagnostic Performance of <sup>68</sup>Ga-PSMA-11 PET/CT Versus Multiparametric MRI for Detection of Intraprostatic Radiorecurrent Prostate Cancer
      You have access
      Diagnostic Performance of 68Ga-PSMA-11 PET/CT Versus Multiparametric MRI for Detection of Intraprostatic Radiorecurrent Prostate Cancer
      Alexander Light, Stefan Lazic, Kate Houghton, Max Bayne, Martin J. Connor, Henry Tam, Hashim U. Ahmed, Taimur T. Shah and Tara D. Barwick
      Journal of Nuclear Medicine March 1, 2024, 65 (3) 379-385; DOI: https://doi.org/10.2967/jnumed.123.266527
  • Translational

    • First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer
      Open Access
      First-in-Human Evaluation of Site-Specifically Labeled 89Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer
      Randy Yeh, Joseph A. O’Donoghue, Vetri Sudar Jayaprakasam, Audrey Mauguen, Ryan Min, Sue Park, Julia P. Brockway, Jacqueline F. Bromberg, W Iris Zhi, Mark E. Robson, Rachel Sanford, Shanu Modi, Brian J. Agnew, Serge K. Lyashchenko, Jason S. Lewis, Gary A. Ulaner and Brian M. Zeglis
      Journal of Nuclear Medicine March 1, 2024, 65 (3) 386-393; DOI: https://doi.org/10.2967/jnumed.123.266392
    • Design, Preclinical Evaluation, and Clinical Translation of <sup>68</sup>Ga-FAPI-LM3, a Heterobivalent Molecule for PET Imaging of Nasopharyngeal Carcinoma
      Open Access
      Design, Preclinical Evaluation, and Clinical Translation of 68Ga-FAPI-LM3, a Heterobivalent Molecule for PET Imaging of Nasopharyngeal Carcinoma
      Liang Zhao, Yizhen Pang, Jianyang Fang, Jianhao Chen, Yangfan Zhou, Long Sun, Hua Wu, Zhide Guo, Qin Lin and Haojun Chen
      Journal of Nuclear Medicine March 1, 2024, 65 (3) 394-401; DOI: https://doi.org/10.2967/jnumed.123.266183
  • Basic

    • Effectiveness of <sup>225</sup>Ac-Labeled Anti-EGFR Radioimmunoconjugate in EGFR-Positive Kirsten Rat Sarcoma Viral Oncogene and BRAF Mutant Colorectal Cancer Models
      You have access
      Effectiveness of 225Ac-Labeled Anti-EGFR Radioimmunoconjugate in EGFR-Positive Kirsten Rat Sarcoma Viral Oncogene and BRAF Mutant Colorectal Cancer Models
      Anjong Florence Tikum, Jessica P. Ketchemen, Alireza Doroudi, Anand K. Nambisan, Hanan Babeker, Fabrice Ngoh Njotu and Humphrey Fonge
      Journal of Nuclear Medicine March 1, 2024, 65 (3) 402-408; DOI: https://doi.org/10.2967/jnumed.123.266204

Theranostics

  • Clinical

    • The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy
      You have access
      The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy
      Surekha Yadav, Courtney Lawhn-Heath, Alan Paciorek, Sheila Lindsay, Rebecca Mirro, Emily K. Bergsland and Thomas A. Hope
      Journal of Nuclear Medicine March 1, 2024, 65 (3) 409-415; DOI: https://doi.org/10.2967/jnumed.123.266614
    • Somatostatin Receptor Imaging with [<sup>18</sup>F]FET-βAG-TOCA PET/CT and [<sup>68</sup>Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative Study
      Open Access
      Somatostatin Receptor Imaging with [18F]FET-βAG-TOCA PET/CT and [68Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative Study
      Suraiya Dubash, Tara D. Barwick, Kasia Kozlowski, Andrea G. Rockall, Sairah Khan, Sameer Khan, Siraj Yusuf, Angela Lamarca, Juan W. Valle, Richard A. Hubner, Mairéad G. McNamara, Andrea Frilling, Tricia Tan, Florian Wernig, Jeannie Todd, Karim Meeran, Bhavesh Pratap, Saleem Azeem, Michael Huiban, Nicholas Keat, Jingky P. Lozano-Kuehne, Eric O. Aboagye and Rohini Sharma
      Journal of Nuclear Medicine March 1, 2024, 65 (3) 416-422; DOI: https://doi.org/10.2967/jnumed.123.266601
    • FEATURED ARTICLE OF THE MONTH

      • Prostate-Specific Membrane Antigen–Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial
        You have access
        Prostate-Specific Membrane Antigen–Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial
        Melline G.M. Schilham, Diederik M. Somford, Heidi V.N. Küsters-Vandevelde, Rick Hermsen, Jean Paul A. van Basten, Robert J. Hoekstra, Tom W.J. Scheenen, Martin Gotthardt, J.P. Michiel Sedelaar and Mark Rijpkema
        Journal of Nuclear Medicine March 1, 2024, 65 (3) 423-429; DOI: https://doi.org/10.2967/jnumed.123.266495
    • INVITED PERSPECTIVE

      • You have access
        The DETECT Trial: Are We on the Verge of Precision Surgery in Primary Prostate Cancer?
        Tobias Maurer, Christian Thomas and Boris Hadaschik
        Journal of Nuclear Medicine March 1, 2024, 65 (3) 430-431; DOI: https://doi.org/10.2967/jnumed.123.267187
    • First Safety and Efficacy Data with the Radiohybrid <sup>177</sup>Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer
      You have access
      First Safety and Efficacy Data with the Radiohybrid 177Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer
      Alexander Dierks, Alexander Gäble, Andreas Rinscheid, Georgine Wienand, Christian H. Pfob, Malte Kircher, Johanna S. Enke, Tilman Janzen, Marianne Patt, Martin Trepel, Dorothea Weckermann, Ralph A. Bundschuh and Constantin Lapa
      Journal of Nuclear Medicine March 1, 2024, 65 (3) 432-437; DOI: https://doi.org/10.2967/jnumed.123.266741
    • Differences and Common Ground in <sup>177</sup>Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers
      You have access
      Differences and Common Ground in 177Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers
      Andrea Farolfi, Wesley R. Armstrong, Loic Djaileb, Andrei Gafita, Masatoshi Hotta, Martin Allen-Auerbach, Lena M. Unterrainer, Wolfgang P. Fendler, Matthew Rettig, Matthias Eiber, Michael S. Hofman, Boris Hadaschik, Ken Herrmann, Johannes Czernin, Jeremie Calais and Matthias R. Benz
      Journal of Nuclear Medicine March 1, 2024, 65 (3) 438-445; DOI: https://doi.org/10.2967/jnumed.123.266391

Neurology

  • Clinical

    • Dopamine Transporter SPECT with 12-Minute Scan Duration Using Multiple-Pinhole Collimators
      You have access
      Dopamine Transporter SPECT with 12-Minute Scan Duration Using Multiple-Pinhole Collimators
      Ralph Buchert, Balazs Szabo, Akos Kovacs, Thomas Buddenkotte, Franziska Mathies, Amir Karimzadeh, Wencke Lehnert, Susanne Klutmann, Attila Forgacs and Ivayla Apostolova
      Journal of Nuclear Medicine March 1, 2024, 65 (3) 446-452; DOI: https://doi.org/10.2967/jnumed.123.266276
    • One-Year Longitudinal Changes in Tau Accumulation on [<sup>18</sup>F]PI-2620 PET in the Alzheimer Spectrum
      You have access
      One-Year Longitudinal Changes in Tau Accumulation on [18F]PI-2620 PET in the Alzheimer Spectrum
      Minyoung Oh, Seung Jun Oh, Sang Ju Lee, Jungsu S. Oh, Seung Yeon Seo, Soorack Ryu, Jee Hoon Roh, Jae-Hong Lee and Jae Seung Kim
      Journal of Nuclear Medicine March 1, 2024, 65 (3) 453-461; DOI: https://doi.org/10.2967/jnumed.123.265893
    • First-in-Human Study of <sup>18</sup>F-SynVesT-2: An SV2A PET Imaging Probe with Fast Brain Kinetics and High Specific Binding
      You have access
      First-in-Human Study of 18F-SynVesT-2: An SV2A PET Imaging Probe with Fast Brain Kinetics and High Specific Binding
      Lindsey R. Drake, Yanjun Wu, Mika Naganawa, Ruth Asch, Chao Zheng, Soheila Najafzadeh, Richard Pracitto, Marcel Lindemann, Songye Li, Jim Ropchan, David Labaree, Paul R. Emery, Mark Dias, Shannan Henry, Nabeel Nabulsi, David Matuskey, Ansel T. Hillmer, Jean-Dominique Gallezot, Richard E. Carson, Zhengxin Cai and Yiyun Huang
      Journal of Nuclear Medicine March 1, 2024, 65 (3) 462-469; DOI: https://doi.org/10.2967/jnumed.123.266470
    • BRIEF COMMUNICATION

      • Triggered Seizures for Ictal SPECT Imaging: A Case Series and Feasibility Study
        You have access
        Triggered Seizures for Ictal SPECT Imaging: A Case Series and Feasibility Study
        Sabry L. Barlatey, Camille G. Mignardot, Cecilia Friedrichs-Maeder, Kaspar Schindler, Roland Wiest, Andreas Nowacki, Matthias Haenggi, Werner J. Z’Graggen, Claudio Pollo, Axel Rominger, Thomas Pyka and Maxime O. Baud
        Journal of Nuclear Medicine March 1, 2024, 65 (3) 470-474; DOI: https://doi.org/10.2967/jnumed.123.266515

Molecular Imaging

  • Basic

    • FEATURED BASIC SCIENCE ARTICLE

      • It’s a Trap! Aldolase-Prescribed C<sub>4</sub> Deoxyradiofluorination Affords Intracellular Trapping and the Tracing of Fructose Metabolism by PET
        You have access
        It’s a Trap! Aldolase-Prescribed C4 Deoxyradiofluorination Affords Intracellular Trapping and the Tracing of Fructose Metabolism by PET
        Alexia Kirby, Dominic Graf, Mojmír Suchý, Nicholas D. Calvert, Thomas A. Charlton, Robert N. Ben, Christina L. Addison and Adam Shuhendler
        Journal of Nuclear Medicine March 1, 2024, 65 (3) 475-480; DOI: https://doi.org/10.2967/jnumed.123.266905
    • BRIEF COMMUNICATION

      • Preclinical Evaluation of Gastrin-Releasing Peptide Receptor Antagonists Labeled with <sup>161</sup>Tb and <sup>177</sup>Lu: A Comparative Study
        You have access
        Preclinical Evaluation of Gastrin-Releasing Peptide Receptor Antagonists Labeled with 161Tb and 177Lu: A Comparative Study
        Nadine Holzleitner, Tatjana Cwojdzinski, Roswitha Beck, Nicole Urtz-Urban, Colin C. Hillhouse, Pascal V. Grundler, Nicholas P. van der Meulen, Zeynep Talip, Stijn Ramaekers, Michiel Van de Voorde, Bernard Ponsard, Angela Casini and Thomas Günther
        Journal of Nuclear Medicine March 1, 2024, 65 (3) 481-484; DOI: https://doi.org/10.2967/jnumed.123.266233

AI/Advanced Image Analysis

  • Need for Objective Task-Based Evaluation of Image Segmentation Algorithms for Quantitative PET: A Study with ACRIN 6668/RTOG 0235 Multicenter Clinical Trial Data
    Open Access
    Need for Objective Task-Based Evaluation of Image Segmentation Algorithms for Quantitative PET: A Study with ACRIN 6668/RTOG 0235 Multicenter Clinical Trial Data
    Ziping Liu, Joyce C. Mhlanga, Huitian Xia, Barry A. Siegel and Abhinav K. Jha
    Journal of Nuclear Medicine March 1, 2024, 65 (3) 485-492; DOI: https://doi.org/10.2967/jnumed.123.266018

The Illustrated Post

  • You have access
    CCK2 Receptor–Targeted PET/CT in Medullary Thyroid Cancer Using [68Ga]Ga-DOTA-CCK-66
    Oliver Viering, Thomas Günther, Nadine Holzleitner, Alexander Dierks, Georgine Wienand, Christian H. Pfob, Ralph A. Bundschuh, Hans-Jürgen Wester, Johanna S. Enke, Malte Kircher and Constantin Lapa
    Journal of Nuclear Medicine March 1, 2024, 65 (3) 493-494; DOI: https://doi.org/10.2967/jnumed.123.266380

Letters to the Editor

  • You have access
    Commentary on “Radioactive Iodine: A Living History”
    Bennett S. Greenspan, Michael S. Hofman and John Buscombe
    Journal of Nuclear Medicine March 1, 2024, 65 (3) 495; DOI: https://doi.org/10.2967/jnumed.123.267016
  • You have access
    [18F]FDG and Lymphomas: Still a Winning Golden Couple in the Era of FAPI-Based Radiotracers
    Priscilla Guglielmo and Laura Evangelista
    Journal of Nuclear Medicine March 1, 2024, 65 (3) 495-496; DOI: https://doi.org/10.2967/jnumed.123.266939
  • You have access
    Reply: [18F]FDG and Lymphomas: Still a Winning Golden Couple in the Era of FAPI-Based Radiotracers
    Xuetao Chen and Xuejuan Wang
    Journal of Nuclear Medicine March 1, 2024, 65 (3) 496-497; DOI: https://doi.org/10.2967/jnumed.123.266989

In Memoriam

  • You have access
    Aruna Bodapati Gambhir, 1962–2023
    Christian Behrenbruch, Andrei Iagaru and Michelle L. James
    Journal of Nuclear Medicine March 1, 2024, 65 (3) 498; DOI: https://doi.org/10.2967/jnumed.124.267375
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 65 (3)
Journal of Nuclear Medicine
Vol. 65, Issue 3
March 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Prostate-Specific Membrane Antigen–Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial
  • It’s a Trap! Aldolase-Prescribed C4 Deoxyradiofluorination Affords Intracellular Trapping and the Tracing of Fructose Metabolism by PET
Sign up for alerts

Jump to

  • This Month in JNM
  • Discussions with Leaders
  • State of the Art
  • Continuing Education
  • Focus on Molecular Imaging
  • Editorial
  • Oncology
    • Clinical
    • Translational
    • Basic
  • Theranostics
    • Clinical
      • FEATURED ARTICLE OF THE MONTH
      • INVITED PERSPECTIVE
  • Neurology
    • Clinical
      • BRIEF COMMUNICATION
  • Molecular Imaging
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
      • BRIEF COMMUNICATION
  • AI/Advanced Image Analysis
  • The Illustrated Post
  • Letters to the Editor
  • In Memoriam
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire